English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, November 19, 2025
OBI-902、米国FDAより胆管癌治療を対象とした希少疾病用医薬品指定を取得
Monday, November 17, 2025
OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma
OBI-902 獲美國 FDA 審核通過治療膽管癌的「孤兒藥」資格認定
OBI-902获美国FDA审核通过用于治疗胆管癌的“孤儿药”资格认定
OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma

Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575